Juliano Michel de Araújo

Juliano Michel de Araújo

Auto-generated profile, based on publicly available information

Juliano Michel de Araújo

Laboratório de Helmintologia e Malacologia Médica, Instituto René Rachou, Fiocruz-MG, Belo Horizonte, Minas Gerais 30190009, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
WBWilma Patrícia de Oliveira Santos Bernardes
Wilma Patrícia de Oliveira Santos Bernardes
JAJuliano Michel de Araújo
Juliano Michel de Araújo
GCGardênia Braz Carvalho
Gardênia Braz Carvalho
CAClarice Carvalho Alves
Clarice Carvalho Alves
ACAline Thaynara de Moura Coelho
Aline Thaynara de Moura Coelho
CFCristina Toscano Fonseca
Cristina Toscano Fonseca
Sm16 is an immunomodulatory protein that seems to play a key role in the suppression of the cutaneous inflammatory response duringSchistosoma mansonipenetration of the skin of definitive hosts. Therefore, Sm16 represents a potential target for protective immune responses induced by vaccination. In this work, we generated the recombinant protein rSm16 and produced polyclonal antibodies against this protein to evaluate its expression during different parasite life-cycle stages and its location on the surface of the parasite. In addition, we analyzed the immune responses elicited by immunization with rSm16 using two different vaccine formulations, as well as its ability to induce protection in Balb/c mice. In order to explore the biological function of Sm16 during the course of experimental infection, RNA interference was also employed. Our results demonstrated that Sm16 is expressed in cercaria and schistosomula and is located in the schistosomula surface. Despite humoral and cellular immune responses triggered by vaccination using rSm16 associated with either Freund’s or alum adjuvants, immunized mice presented no reduction in either parasite burden or parasite egg laying. Knockdown ofSm16gene expression in schistosomula resulted in decreased parasite sizein vitrobut had no effect on parasite survival or egg productionin vivo. Thus, our findings demonstrate that although the vaccine formulations used in this study succeeded in activating immune responses, these failed to promote parasite elimination. Finally, we have shown that Sm16 is not vital for parasite survival in the definitive host and hence may not represent a suitable target for vaccine development.